Archit Organosys jumps on getting nod to incorporate new wholly owned subsidiary
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Archit Organosys is currently trading at Rs. 47.85, up by 6.15 points or 14.75% from its previous closing of Rs. 41.70 on the BSE.
The scrip opened at Rs. 50.00 and has touched a high and low of Rs. 50.00 and Rs. 46.75 respectively. So far 152312 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 54.80 on 06-Oct-2021 and a 52 week low of Rs. 34.10 on 02-Sep-2021.
Last one week high and low of the scrip stood at Rs. 50.00 and Rs. 39.00 respectively. The current market cap of the company is Rs. 97.88 crore.
The promoters holding in the company stood at 57.40%, while Non-Institutions held 42.60% stake in the company.
Archit Organosys has received approval to incorporate new wholly owned subsidiary namely ‘Archit Lifescience’. The proposed new company shall be engaged primarily in the business of manufacturing chemicals namely ethyl acetate, butyl acetate, propyl acetate, acetaldehyde and acetic anhydride. The board of directors at its meeting held on July 25, 2022 has approved the same.
Archit Organosys is on the forefront in the Indian Chemical Industry, producing a variety of Organic Chemicals, Pigments, Specialty Derivatives, Cosmetic Products, Adhesives & Sealants.
